COMINO Study (Protocol number: GR41986)
A 72 weeks study, Phase III, multicenter, randomized, double-masked, active comparator-controlled study to evaluate the efficacy, safety and pharmacokinetics of Faricimab (RO6867461) administered by intravitreal (IVT) injection in patients with macular oedema secondary to central retinal or hemiretinal vein occlusion (HRVO).
ClinicalTrials.gov Identifier: NCT04740931
Principal Investigator: Dr Balaratnasingam, Chandra
For further information about this study, you may visit Clinical Trial Registry: https://clinicaltrials.gov/ct2/show/NCT04740931?term=2020-000441-13&draw=2&rank=1
Or contact the Lions Eye Institute Clinical Trials Office telephone (08) 9381 0750 or email clinicalresearch@lei.org.au
